A detailed history of Wells Fargo & Company transactions in Amgen Inc stock. As of the latest transaction made, Wells Fargo & Company holds 6,600 shares of AMGN stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,600
Previous 7,488,777 99.91%
Holding current value
$2.02 Million
Previous $2.16 Billion 99.91%
% of portfolio
0.0%
Previous 0.57%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $3.74 Million - $4.51 Million
13,905 Added 0.19%
7,502,682 $2.13 Billion
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $23.7 Million - $26.7 Million
-92,642 Reduced 1.22%
7,488,777 $2.16 Billion
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $19.5 Million - $24.2 Million
-89,294 Reduced 1.16%
7,581,419 $2.04 Billion
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $21.1 Million - $24.9 Million
98,374 Added 1.3%
7,670,713 $1.7 Billion
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $40.4 Million - $49.3 Million
178,976 Added 2.42%
7,572,339 $1.83 Billion
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $23.5 Million - $29.9 Million
-102,594 Reduced 1.37%
7,393,363 $1.94 Billion
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $2.9 Million - $3.28 Million
-12,942 Reduced 0.17%
7,495,957 $1.69 Billion
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $22.7 Million - $25.3 Million
-98,549 Reduced 1.3%
7,508,899 $1.83 Billion
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $207 Million - $229 Million
944,683 Added 14.18%
7,607,448 $1.84 Billion
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $53.6 Million - $61.4 Million
-269,747 Reduced 3.89%
6,662,765 $1.5 Billion
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $41.4 Million - $48.5 Million
-195,083 Reduced 2.74%
6,932,512 $1.47 Billion
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $119 Million - $132 Million
-511,012 Reduced 6.69%
7,127,595 $1.74 Billion
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $5.66 Million - $6.59 Million
25,489 Added 0.33%
7,638,607 $1.9 Billion
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $42.1 Million - $50.1 Million
194,587 Added 2.62%
7,613,118 $1.75 Billion
Q3 2020

Nov 05, 2020

SELL
$234.65 - $260.95 $7.31 Million - $8.13 Million
-31,153 Reduced 0.42%
7,418,531 $1.89 Billion
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $54.7 Million - $67.1 Million
276,284 Added 3.85%
7,449,684 $1.76 Billion
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $1.31 Billion - $1.73 Billion
7,173,400 New
7,173,400 $1.45 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $164B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.